Long Term Metformin in Women With Polycystic Ovary Syndrome
NCT ID: NCT04043221
Last Updated: 2019-08-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
180 participants
OBSERVATIONAL
2006-01-01
2019-01-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Each patient's age and height were recorded at baseline. In addition each patient weight, waist circumference, menstrual regularity, fasting glucose, glucose after 120 minute oral glucose tolerance test, luteinizing hormone, follicle stimulating hormone , free and direct testosterone, androstenedione, sex hormone binding globulin, dehydroepiandrosterone sulfate were identified at baseline and at the every follow up visit where available.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Treatment Legacy Effect of Metformin in Obese Women With PCOS
NCT04566718
Efficacy of Metformin in PCOS: Metabolic and Hormonal Factors
NCT00317928
Efficacy of Metformin in Lean Women With Polycystic Ovary Syndrome
NCT00319293
Glucose Metabolism in Different PCOS Phenotypes
NCT03204461
Metformin and Lifestyle Intervention in Women With Polycystic Ovary Syndrome
NCT00679679
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* BMI≥ 25kg/m2
* metformin 1000mg twice a day for at least one year
Exclusion Criteria
* BMI \<25kg/m2
* had been treated with spironolactone or oral contraceptives alone or in combination with metformin
* had history of bariatric surgery
* became pregnant during the observation period
* had inability to tolerate metformin, leading to the cessation of drug therapy within first follow up year
18 Years
55 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Medical Centre Ljubljana
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Andrej Janez
Clinical professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Medical Center Ljubljana
Ljubljana, , Slovenia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MET retro
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.